Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Veltuzumab

😃Good
Catalog No. T76765Cas No. 728917-18-8
Alias IMMU-106, IMMU106, hA20

Veltuzumab (IMMU-106) is a humanized anti-CD20 monoclonal antibody that displays anti-proliferative, apoptotic, and antibody-dependent cytotoxic effects in vitro and inhibits tumor growth in mice harboring human lymphomas, and is indicated for use in non-Hodgkin's lymphoma (NHL).

Veltuzumab

Veltuzumab

😃Good
Catalog No. T76765Alias IMMU-106, IMMU106, hA20Cas No. 728917-18-8
Veltuzumab (IMMU-106) is a humanized anti-CD20 monoclonal antibody that displays anti-proliferative, apoptotic, and antibody-dependent cytotoxic effects in vitro and inhibits tumor growth in mice harboring human lymphomas, and is indicated for use in non-Hodgkin's lymphoma (NHL).
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$197In StockIn Stock
5 mg$463In StockIn Stock
10 mg$742-In Stock
25 mg$1,120-In Stock
50 mg$1,490-In Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:97.7% (SDS-PAGE); 97.9% (SEC-HPLC)
Contact us for more batch information

Product Introduction

Bioactivity
Description
Veltuzumab (IMMU-106) is a humanized anti-CD20 monoclonal antibody that displays anti-proliferative, apoptotic, and antibody-dependent cytotoxic effects in vitro and inhibits tumor growth in mice harboring human lymphomas, and is indicated for use in non-Hodgkin's lymphoma (NHL).
Targets&IC50
Daudi cells:0.08-0.09 μg/mL (EC50)
In vitro
Veltuzumab was effective in reducing dissociation rates in human lymphoma cell lines and enhancing complement-dependent cytotoxicity in 1 of 3 cell lines, but did not exhibit other significant in vitro differences. [1]
Veltuzumab (0.001-10 μg/mL, 3 hours) had low EC50 values ranging from 0.08-0.09 μg/mL in Daudi cell lines. [1]
In vivo
Veltuzumab (intravenous or subcutaneous; 5, 20, and 60 μg; single dose) achieves control of tumor growth, or removal of circulating and adherent B cells, at low doses in mouse models. [1]
Veltuzumab (intraperitoneal; 0.05-35 μg) demonstrated significant efficacy in in vivo studies. [1]
SynonymsIMMU-106, IMMU106, hA20
Reactivity
Human
Application
Functional assay
Antibody Type
Monoclonal
Endotoxin<1.0 EU/mg
Related Conjugates and Formulations
Conjucates
Unconjugated
Antigen Details
Gene ID
Uniprot ID
TargetCD20
Chemical Properties
Molecular Weight145.33 kDa
Cas No.728917-18-8
ColorTransparent
AppearanceLiquid
Antibody Information
IsotypeHuman IgG1 kappa
Recommended Isotype Control
Storage & Solubility Information
Storagestore at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.

Calculator

  • Dilution Calculator
  • Reconstitution Calculator

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Related Tags: buy Veltuzumab | purchase Veltuzumab | Veltuzumab cost | order Veltuzumab | Veltuzumab in vivo | Veltuzumab in vitro | Veltuzumab molecular weight